Kulkarni; Shirishkumar
Patent Applications and Registrations
Patent applications and USPTO patent grants for Kulkarni; Shirishkumar.The latest application filed is for "solid dispersion of rifaximin".
Company Profile
5.23.37
- Kulkarni; Shirishkumar - Maharashtra IN
- KULKARNI; Shirishkumar - Pune IN
Patent Activity
| Patent | Date |
|---|---|
| Modified release formulation of lacosamide Grant 11,278,502 - Kulkarni , et al. March 22, 2 | 2022-03-22 |
| Solid Dispersion Of Rifaximin App 20200375959 - KULKARNI; Shirishkumar ; et al. | 2020-12-03 |
| Controlled release pharmaceutical dosage forms Grant 10,842,802 - Chandran , et al. November 24, 2 | 2020-11-24 |
| Modified release formulation of lacosamide Grant 10,786,464 - Kulkarni , et al. September 29, 2 | 2020-09-29 |
| Rifaximin Ready-to-use Suspension App 20190192490 - Jahagirdar; Harshal Anil ; et al. | 2019-06-27 |
| Pharmaceutical Compositions For Gastrointestinal Drug Delivery App 20190076536 - JAHAGIRDAR; Harshal Anil ; et al. | 2019-03-14 |
| Modified Release Formulation Of Lacosamide App 20190029968 - Kulkarni; Shirishkumar ; et al. | 2019-01-31 |
| Rifaximin ready-to-use suspension Grant 10,137,114 - Jahagirdar , et al. November 27, 2 | 2018-11-27 |
| Pharmaceutical compositions for gastrointestinal drug delivery Grant 9,931,405 - Jahagirdar , et al. April 3, 2 | 2018-04-03 |
| Controlled release pharmaceutical compositions of tapentadol Grant 9,884,022 - Deshmukh , et al. February 6, 2 | 2018-02-06 |
| Oral controlled release pharmaceutical compositions of Bepotastine Grant 9,820,936 - Deshmukh , et al. November 21, 2 | 2017-11-21 |
| Oral Controlled Release Pharmaceutical Compositions Of Bepotastine App 20170027863 - DESHMUKH; Ashish Ashokrao ; et al. | 2017-02-02 |
| Oral controlled release pharmaceutical compositions of bepotastine Grant 9,421,165 - Deshmukh , et al. August 23, 2 | 2016-08-23 |
| Rifaximin Ready-to-use Suspension App 20160136141 - JAHAGIRDAR; Harshal Anil ; et al. | 2016-05-19 |
| Rifaximin ready-to-use suspension Grant 9,211,258 - Jahagirdar , et al. December 15, 2 | 2015-12-15 |
| Pharmaceutical Compositions For Gastrointestinal Drug Delivery App 20150343070 - JAHAGIRDAR; Harshal Anil ; et al. | 2015-12-03 |
| Oral compositions of clindamycin Grant 9,040,089 - Walzade , et al. May 26, 2 | 2015-05-26 |
| Pharmaceutical compositions for gastrointestinal drug delivery Grant 8,974,825 - Jahagirdar , et al. March 10, 2 | 2015-03-10 |
| Bilayer Tablet of Dronedarone App 20150017242 - Deshmukh; Ashish Ashokrao ; et al. | 2015-01-15 |
| Controlled release pharmaceutical compositions of milnacipran Grant 8,916,194 - Kulkarni , et al. December 23, 2 | 2014-12-23 |
| Controlled Release Pharmaceutical Dosage Forms App 20140274970 - CHANDRAN; Sajeev ; et al. | 2014-09-18 |
| Solid Dispersion Of Rifaximin App 20140221414 - KULKARNI; Shirishkumar ; et al. | 2014-08-07 |
| Controlled Release Pharmaceutical Compositions Of Selective Serotonin Reuptake Inhibitor App 20140010883 - Jahagirdar; Harshal ; et al. | 2014-01-09 |
| Process for preparing pharmaceutical ophthalmic compositions Grant 8,614,210 - Bhutada , et al. December 24, 2 | 2013-12-24 |
| Sustained Release Composition of Memantine App 20130323309 - Bhutada; Pravin Meghrajji ; et al. | 2013-12-05 |
| Oral Controlled Release Pharmaceutical Compositions Of Bepotastine App 20130317063 - Deshmukh; Ashish Ashokrao ; et al. | 2013-11-28 |
| Taste-masked Powder For Suspension Compositions Of Methylprednisolone App 20130203721 - Bhutada; Pravin Meghrajji ; et al. | 2013-08-08 |
| Controlled Release Pharmaceutical Compositions of Milnacipran App 20130156854 - Kulkarni; Shirishkumar ; et al. | 2013-06-20 |
| Oral Controlled Release Pharmaceutical Compositions Of Blonanserin App 20130143897 - Bhutada; Pravin Meghrajji ; et al. | 2013-06-06 |
| Rifaximin Ready-to-use Suspension App 20130072512 - Jahagirdar; Harshal Anil ; et al. | 2013-03-21 |
| Pharmaceutical compositions of rifaximin Grant 8,383,151 - Jahagirdar , et al. February 26, 2 | 2013-02-26 |
| Controlled Release Pharmaceutical Compositions Of Tapentadol App 20130022654 - Deshmukh; Ashish Ashokrao ; et al. | 2013-01-24 |
| Slow Release Pharmaceutical Compositions Of Iloperidone App 20130004545 - Bhutada; Pravin Meghrajji ; et al. | 2013-01-03 |
| Process For Preparing Pharmaceutical Ophthalmic Compositions App 20120283252 - Bhutada; Pravin Meghrajji ; et al. | 2012-11-08 |
| Modified Release Formulation Of Lacosamide App 20120219631 - Kulkarni; Shirishkumar ; et al. | 2012-08-30 |
| Solid Dispersion Of Rifaximin App 20120214833 - Kulkarni; Shirishkumar ; et al. | 2012-08-23 |
| Pharmaceutical Compositions For Gastrointestinal Drug Delivery App 20120027855 - DESHMUKH; Ashish Ashokrao ; et al. | 2012-02-02 |
| Oral Compositions Of Clindamycin App 20110123631 - Walzade; Kalpana ; et al. | 2011-05-26 |
| Modified Release Formulations Of Hmg Coa Reductase Inhibitors App 20110003837 - KULKARNI; Sheetal ; et al. | 2011-01-06 |
| Novel Reduced Dose Pharmaceutical Compositions Of Fexofenadine And Pseudoephedrine App 20100143471 - Udhumansha; Ubaidulla ; et al. | 2010-06-10 |
| Pharmaceutical Compositions Of Rifaximin App 20090028940 - Jahagirdar; Harshal Anil ; et al. | 2009-01-29 |
| Pharmaceutical Compositions For Gastrointestinal Drug Delivery App 20090011019 - Jahagirdar; Harshal Anil ; et al. | 2009-01-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 